MyMD Pharmaceuticals, Inc. (MYMD)
Stock Price: $4.96 USD
0.17 (3.55%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Numbers in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 1.67 | 3.35 | 2.96 | 2.12 | 4.43 | 3.58 | 1.56 | 1.79 | |
| Revenue Growth | - | - | -50.35% | 13.3% | 39.99% | -52.23% | 23.74% | 128.75% | -12.38% | - | |
| Cost of Revenue | - | - | 1.54 | 2.41 | 1.08 | 0.95 | 1.18 | 1.91 | 1.01 | 0.96 | |
| Gross Profit | - | - | 0.13 | 0.95 | 1.88 | 1.16 | 3.25 | 1.66 | 0.56 | 0.83 | |
| Selling, General & Admin | 4.32 | 3.40 | 7.45 | 6.13 | 5.15 | 6.57 | 5.28 | 2.21 | 2.13 | 3.90 | |
| Research & Development | 7.96 | - | 1.06 | 1.26 | 1.19 | 1.41 | 0.92 | 1.01 | 0.90 | 0.89 | |
| Other Operating Expenses | 0.00 | 0.08 | 1.68 | 0.17 | -1.13 | 2.87 | 0.26 | 0.26 | 0.26 | 0.26 | |
| Operating Expenses | 12.29 | 3.47 | 10.19 | 7.56 | 5.21 | 10.85 | 6.46 | 3.47 | 3.29 | 5.04 | |
| Operating Income | -12.29 | -3.47 | -10.06 | -6.61 | -3.33 | -9.68 | -3.20 | -1.81 | -2.74 | -4.21 | |
| Other Expense / Income | 5.29 | 0.42 | 0.79 | 0.75 | -0.03 | -0.10 | -0.06 | -0.28 | -0.01 | -0.29 | |
| Pretax Income | -17.58 | -3.89 | -10.85 | -7.37 | -3.30 | -9.58 | -3.14 | -1.53 | -2.73 | -3.92 | |
| Income Tax | - | - | - | - | - | -0.27 | - | - | -0.17 | -0.30 | |
| Net Income | -17.58 | -3.89 | -10.85 | -7.37 | -3.30 | -9.31 | -3.14 | -1.53 | -2.56 | -3.63 | |
| Shares Outstanding (Basic) | 3.53 | 0.31 | 0.24 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Shares Outstanding (Diluted) | 3.53 | 0.31 | 0.24 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Shares Change | 1051.14% | 25.82% | 897.44% | 72.62% | 5.62% | 8.33% | 197.23% | 39.67% | 9.25% | - | |
| EPS (Basic) | -4.98 | -12.70 | -44.56 | -301.92 | -234.24 | -695.04 | -253.44 | -368.64 | -860.16 | -1,332.48 | |
| EPS (Diluted) | -4.98 | -12.70 | -44.56 | -301.92 | -234.24 | -695.04 | -253.44 | -368.64 | -860.16 | -1,332.48 | |
| Free Cash Flow Per Share | -3.38 | -10.02 | -35.20 | -210.36 | -303.83 | -391.80 | -316.29 | -686.16 | -339.59 | -921.02 | |
| Gross Margin | - | - | 7.6% | 28.3% | 63.4% | 55% | 73.5% | 46.5% | 35.6% | 46.4% | |
| Operating Margin | - | - | -604.0% | -197.1% | -112.4% | -457.8% | -72.4% | -50.6% | -174.9% | -236.0% | |
| Profit Margin | - | - | -651.4% | -219.6% | -111.6% | -440.3% | -71% | -42.7% | -163.5% | -203.2% | |
| FCF Margin | - | - | -514.6% | -153.1% | -145.1% | -248.0% | -88.3% | -79.7% | -64.6% | -140.6% | |
| EBITDA | -17.55 | -3.81 | -10.61 | -7.12 | -3.02 | -9.28 | -2.79 | -1.17 | -2.35 | -3.55 | |
| EBITDA Margin | - | - | -637.3% | -212.1% | -101.9% | -438.8% | -63.1% | -32.8% | -150.5% | -198.7% | |
| EBIT | -17.58 | -3.89 | -10.85 | -7.37 | -3.30 | -9.58 | -3.14 | -1.53 | -2.73 | -3.92 | |
| EBIT Margin | - | - | -651.4% | -219.6% | -111.6% | -453.0% | -71.0% | -42.7% | -174.2% | -219.9% |